xenon xe-133 · Ge Healthcare · NDA 017256, 017283, 017284, 017550, 017687, 018327

Xenon Xe 133

Earliest generic entry, as listed · earliest of 11 marketed strengths
Open now

No marketed reference-listed strength; date taken from all listed strengths.

No unexpired patents or exclusivities are listed for this product.

Listed patents · 0 unexpired

No unexpired patents listed.

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 11

NDA · productFormStrengthListed expiry
017256 · 001 · discontinuedinjectable, injection1.3-1.7 CI/AMPopen
017256 · 002 · discontinuedgas, inhalation1 CI/AMPopen
017283 · 001 · discontinuedinjectable, injection6.3mCi/MLopen
017284 · 001gas, inhalation10mCi/VIALopen
017284 · 002gas, inhalation20mCi/VIALopen
017550 · 001 · discontinuedgas, inhalation5-100 CI/CYLINDERopen
017550 · 003 · discontinuedgas, inhalation0.25-5 CI/AMPopen
017687 · 002 · discontinuedgas, inhalation10mCi/VIALopen
017687 · 003 · discontinuedgas, inhalation20mCi/VIALopen
018327 · 001gas, inhalation10mCi/VIALopen
018327 · 002gas, inhalation20mCi/VIALopen